Stay up to date

News

see all news
Proteomedix appoints Dr Maurizio Ballerini, MD as VP Market Development EMEA and Dr Helene Peyro Saint-Paul, MD as Medical Advisor

May 26, 2020

Analytical performance of Proclarix® verified

May 19, 2020

Publications

see all publications
Analytical performance of thrombospondin-1 and cathepsin D immunoassays part of a novel CE-IVD marked test as an aid in the diagnosis of prostate cancer.

Macagno, A., Athanasiou, A., Wittig, A., Huber, R., Weber, S., Keller, T., Rhiel, M., Golding, B., Schiess, R. PloS one 15(5), 2020.

Development and validation of a novel multivariate risk score to guide biopsy decision for the diagnosis of clinically significant prostate cancer.

Klocker H, Golding B, Weber S, Steiner E, Tennstedt P, Keller T, Schiess R, Gillessen S, Horninger W, Steuber T. BJUI Compass. 2020;1:15–20.

Events

see all events
Postponed to Dec 13th-17th, 2020 - 2020 AACC Annual Scientific Meeting & Clinical Lab Expo

Chicago, US

Sep 23rd-26th, 2020 - Jahreskongress der Deutschen Gesellschaft für Urologie e.V.

Leipzig, DE